Identifying causes of variability in outcomes in children with acute lymphoblastic leukemia treated in a resource‐rich developing country

Abstract

Despite the encouraging results observed in the present study, our patients displayed significantly lower survival outcomes compared to subjects treated in major clinical trials conducted by leading leukemia cooperative groups. Furthermore, this work underscores the need for targeted interventions to reduce death as the first event in developing regions.